Santos, Rafael Guimarães dos 1980-
Rafael G Dos Santos researcher
VIAF ID: 88509631 (Personal)
Permalink: http://viaf.org/viaf/88509631
Preferred Forms
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report | |
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years | |
Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. | |
Ayahuasca Alters Structural Parameters of the Rat Aorta. | |
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users | |
Ayahuasca intoxication | |
Ayahuasca religions, c2008: | |
Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV) | |
A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions | |
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. | |
Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination | |
Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies. | |
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms? | |
Letter to the Editor | |
Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder | |
Personality Inventory for DSM-5 (PID-5): cross-cultural adaptation and content validity in the Brazilian context | |
Pharmacology of ayahuasca administered in two repeated doses | |
Phytocannabinoids and epilepsy | |
Possible Interactions Between 5-HT2A Receptors and the Endocannabinoid System in Humans: Preliminary Evidence of Interactive Effects of Ayahuasca and Endocannabinoids in a Healthy Human Subject | |
Potential therapeutic effects of psilocybin/psilocin are minimized while possible adverse reactions are overrated | |
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial | |
Religiões ayahuasqueiras : um balanço bibliográfico | |
Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects | |
Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology. | |
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials | |
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature | |
Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer | |
Serotonergic psychedelics and personality: A systematic review of contemporary research. | |
Toxicity of chronic ayahuasca administration to the pregnant rat: how relevant it is regarding the human, ritual use of ayahuasca? | |
Translational evidence for ayahuasca as an antidepressant: what's next? | |
Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020) | |
Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey. | |
সম্পাদককে চিঠি |